Hot pre-market trades in US stocks: Adagio Medical pre-market down 7.83%; Teradyne pre-market down 4.17%

Pre-market Hot Trades in US Stocks Adagio Medical is down 7.83% in pre-market trading. Based on recent key news: On April 26, Adagio Medical announced positive results from its vCLAS® ventricular ablation system in the FULCRUM-VT pivotal IDE trial. The trial showed that 84% of patients were free from shock, 59% were free from recurrent ventricular tachycardia, and 98% of target ventricular tachycardia was non-inducible at the end of the procedure. This result boosted market confidence in the company's technology, driving the stock price up. On April 27, Adagio Medical's stock rose 11.92% in pre-market trading, reaching $1.69. According to Benzinga Pro data, this increase reflects the market's positive reaction to the company's recent trial results. On April 27, Adagio Medical's stock price was 58.9% above its 100-day simple moving average, indicating a bullish trend in the medium term. The relative strength index (RSI) was 60.15, suggesting that the stock is neither overbought nor oversold, with room for further upside. The medical device industry has shown stable performance recently, with attention on policy changes. Teradyne is down 4.17% in pre-market trading. Based on recent key news: On April 27, Universal Robots partnered with Scale AI to develop the UR AI Trainer, promoting the development of AI technology in industrial applications. This news may raise market concerns about Teradyne's future technology layout, leading to a decline in stock price. On April 25, Teradyne has performed excellently over the past five years, with an average annual return of 26.1%. However, recent market doubts about its future growth potential may put pressure on the stock price. On April 27, market attention on AI-related companies has increased, and some investors may shift towards other AI companies, affecting Teradyne's stock price. AI technology has broad prospects in industrial applications, with high market attention. Top Gainers in Pre-market US Stocks Nexera Tech is up 80.50% in pre-market trading, with no significant recent news. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Baiya is up 51.50% in pre-market trading, with no significant recent news. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Bed Bath & Beyond is up 29.40% in pre-market trading. Based on recent key news: On April 28, Bed Bath & Beyond announced its first-quarter financial report, with revenue increasing by 6.9% to $248 million, exceeding market expectations. The adjusted loss per share was 25 cents, narrowing from 42 cents in the same period last year This performance drove the stock price up. Source: Benzinga On April 28, the company announced it would cut over $60 million in costs over the next nine months by streamlining its structure and integrating operations to improve efficiency. This move is seen as an early sign of the company's recovery. Source: SEC announcement On April 28, Jefferies analysts pointed out that although the company shows signs of recovery, its acquisition-driven strategy carries execution risks, limiting short-term upside potential. Source: Jefferies analysis report on signs of recovery in the retail industry, with ongoing macroeconomic uncertainties